HLA-DRB1 and HLA-DQB1 methylation changes promote the occurrence and progression of Kazakh ESCC

Epigenetics

Volumn 9, Issue 10, 2014, Pages 1366-1373

  Hu, Jian Ming ^a,b   Li, Ling ^a   Chen, Yun Zhao ^a   Liu, Chunxia ^a   Cui, Xiaobin ^a   Yin, Liang ^a   Yang, Lan ^a   Zou, Hong ^a   Pang, Lijuan ^a   Zhao, Jin ^a   Qi, Yan ^a   Cao, Yuwen ^a   Jiang, Jinfang ^a   Liang, Weihua ^a   Li, Feng ^a,b  

^a SHIHEZI UNIVERSITY   (China)

^b HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

DNA methylation; Esophageal squamous cell carcinoma; HLA; Kazakh; Massarray

Indexed keywords

CD45 ANTIGEN; HLA DQB1 ANTIGEN; HLA DRB1 ANTIGEN; HLA DQ ANTIGEN; HLA-DQB1 ANTIGEN;

ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; CANCER STAGING; CLUSTER ANALYSIS; CONTROLLED STUDY; DNA METHYLATION; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; FEMALE; GENE OVEREXPRESSION; GENE SEQUENCE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KAZAKH ESOPHAGEAL SQUAMOUS CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; MASS SPECTROMETRY; POLYMERASE CHAIN REACTION; PROMOTER REGION; TUMOR DIFFERENTIATION; CASE CONTROL STUDY; ESOPHAGUS TUMOR; ETHNOLOGY; GENETIC EPIGENESIS; GENETICS; KAZAKHSTAN; MIDDLE AGED; SQUAMOUS CELL CARCINOMA;

ADULT; AGED; CARCINOMA, SQUAMOUS CELL; CASE-CONTROL STUDIES; DNA METHYLATION; EPIGENESIS, GENETIC; ESOPHAGEAL NEOPLASMS; FEMALE; HLA-DQ BETA-CHAINS; HLA-DRB1 CHAINS; HUMANS; KAZAKHSTAN; MALE; MIDDLE AGED; NEOPLASM STAGING; PROMOTER REGIONS, GENETIC;

EID: 84922025337     PISSN: 15592294     EISSN: 15592308     Source Type: Journal    
DOI: 10.4161/15592294.2014.969625     Document Type: Article

References (24)

1. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA: a Cancer J Clin 2005; 55(2): 74- 108; PMID:15761078
2. Y Z. The distribution of esophageal cancer in Xinjiang. J Xinjiang Med Univ (China) 1988; 11: 139-144
3. Cheung WY, Liu G. Genetic variations in esophageal cancer risk and prognosis. Gastroenterol Clin North Am 2009; 38(1): 75-91; viii PMID:19327568; http:// dx.doi.org/10.1016/j.gtc.2009.01.009
4. Hu J, Li L, Pang L, Chen Y, Yang L, Liu C, Zhao J, Chang B, Qi Y, Liang W, Li F. HLA-DRB1*1501 and HLA-DQB1*0301 alleles are positively associated with HPV16 infection-related Kazakh esophageal squamous cell carcinoma in Xinjiang China. Cancer Immunol, Immunother: CII 2012; 61(11): 2135-2141; PMID: 22588649; http://dx.doi.org/10.1007/s00262-012- 1281-x
5. Mota F, Rayment N, Chong S, Singer A, Chain B. The antigen-presenting environment in normal and human papillomavirus (HPV)-related premalignant cervical epithelium. Clin Exp Immunol 1999; 116(1):33-40; PMID:10209502; PMCID:1905217
6. Kollaee A, Ghaffarpor M, Ghlichnia HA, Ghaffari SH, Zamani M. The influence of the HLA-DRB1 and HLADQB1 allele heterogeneity on disease risk and severity in Iranian patients with multiple sclerosis. Int J Immunogenet 2012; 39(5): 414-422; PMID:22404765; http://dx.doi.org/10.1111/j.1744-313X.2012.01104.x
7. Madeleine MM, Johnson LG, Smith AG, Hansen JA, Nisperos BB, Li S, Zhao LP, Daling JR, Schwartz SM, Galloway DA. Comprehensive analysis of HLA-A, HLA-B, HLA-C, HLA-DRB1, and HLA-DQB1 loci and squamous cell cervical cancer risk. Cancer Res 2008; 68(9):3532-3539; PMID:18451182; PMCID: 2662593; http://dx.doi.org/10.1158/0008-5472.CAN- 07-6471
8. Baccar A, Ferchichi I, Troudi W, Marrakchi R, Ben Hmida N, Jebini S, Mrad K, Ben Romdhane K, Benammar Elgaaied A. CD99 and HLA-II immunostaining in breast cancer tissue and their correlation with lymph node metastasis. Disease Markers 2013; 34 (5):363-371; PMID:23481630; http://dx.doi.org/ 10.3233/DMA-130982
9. Jordanova ES, Philippo K, Giphart MJ, Schuuring E, Kluin PM. Mutations in the HLA class II genes leading to loss of expression of HLA-DR and HLA-DQ in diffuse large B-cell lymphoma. Immunogenetics 2003; 55 (4):203-209; PMID:12756506; http://dx.doi.org/ 10.1007/s00251-003-0563-z
10. Hu Jianming, Chen YZ, Liu Chuxia, Li Wenting, Yin liang, Kang Xueling, Wang Weiwei, Liu Dong, Liang Weihua, Jiang Jinfang, Li Hongan, Li Feng. Expression and Significance Of Human Leukocyte Antigen HLADP, DQ,DR in Xinjiang Kazakh Esophageal Carcinoma. J Shihezi University(China) 2009; 6:731-734
11. Chang CH, Flavell RA. Class II transactivator regulates the expression of multiple genes involved in antigen presentation. J Exp Med 1995; 181(2):765-767; PMID:7836928 PMCID:2191893
12. Ting JP, Trowsdale J. Genetic control of MHC class II expression. Cell 2002; 109 Suppl:S21-33; PMID: 11983150
13. Steidl C, Shah SP, Woolcock BW, Rui L, Kawahara M, Farinha P, Johnson NA, Zhao Y, Telenius A, Neriah SB, et al. MHC class II transactivator CIITA is a recurrent gene fusion partner in lymphoid cancers. Nature 2011; 471 (7338):377-381; PMID:21368758; http:// dx.doi.org/10.1038/nature09754
14. Xie XW, Mei MH, Liao WJ, Qian LH, Yu X, Fei R, Qin LL, Zhang HH, Peng JR, Shen DH, et al. Expression of CIITA-related MHCII molecules in tumors linked to prognosis in hepatocellular carcinoma. Int JOncol 2009; 34(3):681-688; PMID:19212673
15. Zhou JH, Ye F, Chen HZ, Zhou CY, Lu WG, Xie X. Altered expression of cellular membrane molecules of HLA-DR, HLA-G and CD99 in cervical intraepithelial neoplasias and invasive squamous cell carcinoma. Life Sci 2006; 78(22):2643-2649; PMID:16434060; http:// dx.doi.org/10.1016/j.lfs.2005.10.039
16. Glew SS, Duggan-Keen M, Cabrera T, Stern PL. HLA class II antigen expression in human papillomavirusassociated cervical cancer. Cancer Res 1992; 52(14): 4009-4016; PMID:1377602
17. Jo YS, Lee JC, Li S, Choi YS, Bai YS, Kim YJ, Lee IS, Rha SY, Ro HK, Kim JM, et al. Significance of the expression of major histocompatibility complex class II antigen, HLA-DR and -DQ, with recurrence of papillary thyroid cancer. International journal of cancer Journal international du cancer 2008; 122(4): 785- 790; PMID:17957790; http://dx.doi.org/10.1002/ ijc.23167
18. Sumiyoshi K, Kuwano H, Watanabe M, Kitamura M, Toh Y, Sugimachi K. HLA-DR antigen expression in squamous epithelial dysplasia and squamous cell carcinoma of the esophagus: an immunohistochemical study. Oncol Rep 1999; 6(2):301-306; PMID: 10022993
19. Radpour R, Haghighi MM, Fan AX, Torbati PM, Hahn S, Holzgreve W, Zhong XY. High-throughput hacking of the methylation patterns in breast cancer by in vitro transcription and thymidine-specific cleavage mass array on MALDI-TOF silico-chip. Mol Cancer Res: MCR 2008; 6(11):1702-1709; PMID:19010818; http://dx.doi.org/10.1158/1541-7786.MCR-08-0262
20. De Lerma Barbaro A, De Ambrosis A, Banelli B, Li Pira G, Aresu O, Romani M, Ferrini S, Accolla RS. Methylation of CIITA promoter IV causes loss of HLA-II inducibility by IFN-gamma in promyelocytic cells. Int Immunol 2008; 20(11):1457-1466; PMID:18829986; PMCID:2572003; http://dx.doi. org/10.1093/intimm/dxn103
21. Wang C, Cicek MS, Charbonneau B, Kalli KR, Armasu SM, Larson MC, Konecny GE, Winterhoff B, Fan JB, Bibikova M, Chien J, Shridhar V, Block MS, Hartmann LC, Visscher DW, Cunningham JM, Knutson KL, Fridley BL, Goode EL. Tumor hypomethylation at 6p21.3 associates with longer time to recurrence of high-grade serous epithelial ovarian cancer. Cancer Res 2014; 74(11):3084-3091; http://dx.doi.org/ 10.1158/0008-5472. CAN-13-3198
22. Stanley RHLAA. WHO Classification Tumours of the Digestive System. IARC Press Lyon 2000; 9-11
23. Shi SR, Cote RJ, Wu L, Liu C, Datar R, Shi Y, Liu D, Lim H, Taylor CR. DNA extraction from archival formalin- fixed, paraffin-embedded tissue sections based on the antigen retrieval principle: heating under the influence of pH. J Histochem Cytochem 2002; 50 (8):1005-1011; PMID:12133903
24. Thompson RF, Suzuki M, Lau KW, Greally JM. A pipeline for the quantitative analysis of CG dinucleotide methylation using mass spectrometry. Bioinformatics 2009; 25(17):2164-2170; PMID:19561019; PMCID:2800352; http://dx.doi.org/10.1093/ bioinformatics/btp382